Browse studies

Find your next paid study

1 recruiting study matching your filters

Epcoritamab in Combination With R-CHOP Debulking in Newly Diagnosed Patients With Aggressive Non-Hodgkin Lymphoma

A Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggress…

Non-Hodgkin's B-cell LymphomaLymphoma Non-HodgkinDiffuse Large B-Cell Lymphoma (DLBCL)

Estimated

~$10 – $7,500

Mwanasha Merrill, MDNCT07588698